John A MacPhee Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for John A MacPhee.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of John A MacPhee. John A MacPhee is EVP, Pres - Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres Strativa Pharma in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Strativa Pharma in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres.-Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, President, Strativa Pharm in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Branded Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres, Strativa Pharm in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Pres, Branded Products Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Pres. Branded Products Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Director in Adamas Pharmaceuticals Inc ($ADMS).

Latest Insider Trading Transactions of John A MacPhee

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADMS, PRX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 16 2021	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Option Exercise	M	0.67	192,000	127,680	0
Mar 16 2021	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Buy	M	0.67	192,000	127,680	197,000	5 K to 197 K (+3,840.00 %)
Jun 05 2020	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Option Exercise	A	2.70	10,000	27,000	10,000
Jun 05 2020	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Grant	A	0.00	5,000	0	5,000	0 to 5 K
Jun 06 2019	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Option Exercise	A	4.80	10,000	48,000	10,000
Jun 07 2018	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Option Exercise	A	27.98	10,000	279,800	10,000
Jun 02 2017	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Option Exercise	A	16.27	15,000	244,050	15,000
Aug 08 2016	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Option Exercise	A	13.68	12,600	172,368	12,600
Jun 07 2016	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Option Exercise	A	17.03	15,000	255,450	15,000
May 18 2015	ADMS	Adamas Pharmaceuti ...	MacPhee John A	Director	Option Exercise	A	17.97	21,000	377,370	21,000
Jan 13 2011	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	35.98	19,006	683,836	105,903	124.9 K to 105.9 K (-15.22 %)
Jan 13 2011	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Grant	A	0.00	21,603	0	124,909	103.3 K to 124.9 K (+20.91 %)
Jan 06 2011	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	39.79	1,100	43,769	103,306	104.4 K to 103.3 K (-1.05 %)
Dec 22 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	38.26	2,347	89,796	104,406	106.8 K to 104.4 K (-2.20 %)
Nov 19 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	37.72	13,043	491,982	105,989	119 K to 106 K (-10.96 %)
Mar 24 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	25.09	1,732	43,456	119,032	120.8 K to 119 K (-1.43 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.10	100	2,510	120,764	120.9 K to 120.8 K (-0.08 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.09	100	2,509	120,864	121 K to 120.9 K (-0.08 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.08	400	10,032	120,964	121.4 K to 121 K (-0.33 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.07	1,205	30,209	121,364	122.6 K to 121.4 K (-0.98 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.06	1,935	48,491	122,569	124.5 K to 122.6 K (-1.55 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.05	7,582	189,929	124,504	132.1 K to 124.5 K (-5.74 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.04	3,171	79,402	132,086	135.3 K to 132.1 K (-2.34 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.04	100	2,504	135,257	135.4 K to 135.3 K (-0.07 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.03	3,299	82,574	135,357	138.7 K to 135.4 K (-2.38 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.02	3,802	95,126	138,586	142.4 K to 138.6 K (-2.67 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.02	200	5,003	142,388	142.6 K to 142.4 K (-0.14 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.01	2,800	70,028	142,588	145.4 K to 142.6 K (-1.93 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.00	3,129	78,225	145,388	148.5 K to 145.4 K (-2.11 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	25.00	100	2,500	148,517	148.6 K to 148.5 K (-0.07 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.99	3,409	85,191	148,617	152 K to 148.6 K (-2.24 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.98	1,578	39,418	152,026	153.6 K to 152 K (-1.03 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.97	2,400	59,928	153,604	156 K to 153.6 K (-1.54 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.96	900	22,464	156,004	156.9 K to 156 K (-0.57 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.95	1,100	27,445	156,904	158 K to 156.9 K (-0.70 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.94	200	4,988	158,004	158.2 K to 158 K (-0.13 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.93	200	4,986	158,204	158.4 K to 158.2 K (-0.13 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.92	200	4,984	158,404	158.6 K to 158.4 K (-0.13 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.91	700	17,437	158,604	159.3 K to 158.6 K (-0.44 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.89	300	7,467	159,304	159.6 K to 159.3 K (-0.19 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.88	200	4,976	159,604	159.8 K to 159.6 K (-0.13 %)
Mar 10 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Sell	S	24.87	800	19,896	159,804	160.6 K to 159.8 K (-0.50 %)
Jan 12 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres - Strativ ...	Payment of Exercise	F	25.80	1,017	26,239	160,380	161.4 K to 160.4 K (-0.63 %)
Jan 12 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres - Strativ ...	Payment of Exercise	F	25.80	1,349	34,804	161,397	162.7 K to 161.4 K (-0.83 %)
Jan 06 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Option Exercise	A	27.71	23,457	649,993	23,457
Jan 06 2010	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Grant	A	0.00	11,729	0	162,746	151 K to 162.7 K (+7.77 %)
Dec 22 2009	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	26.04	1,807	47,054	151,017	152.8 K to 151 K (-1.18 %)
Sep 10 2009	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	21.19	628	13,307	152,502	153.1 K to 152.5 K (-0.41 %)
Mar 24 2009	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	11.19	1,732	19,381	152,057	153.8 K to 152.1 K (-1.13 %)
Jan 14 2009	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	12.59	1,017	12,804	153,789	154.8 K to 153.8 K (-0.66 %)
Jan 12 2009	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres.-Strativa	Option Exercise	A	13.06	99,541	1,300,005	99,541
Jan 12 2009	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres.-Strativa	Payment of Exercise	F	12.83	1,599	20,515	154,806	156.4 K to 154.8 K (-1.02 %)
Jan 12 2009	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres.-Strativa	Payment of Exercise	F	13.59	496	6,741	156,405	156.9 K to 156.4 K (-0.32 %)
Dec 23 2008	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa	Payment of Exercise	F	12.43	1,807	22,461	156,432	158.2 K to 156.4 K (-1.14 %)
Nov 20 2008	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, President, Str ...	Option Exercise	A	10.99	102,881	1,130,662	102,881
Nov 20 2008	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, President, Str ...	Grant	A	0.00	45,496	0	158,239	112.7 K to 158.2 K (+40.35 %)
Oct 20 2008	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres Strativa ...	Buy	P	10.63	7,500	79,709	112,743	105.2 K to 112.7 K (+7.13 %)
Sep 11 2008	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres-Strativa ...	Payment of Exercise	F	14.22	628	8,930	104,693	105.3 K to 104.7 K (-0.60 %)
Mar 26 2008	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	EVP, Pres Strativa ...	Payment of Exercise	F	18.37	1,732	31,817	103,802	105.5 K to 103.8 K (-1.64 %)
Jan 15 2008	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	Exec VP, Pres, Stra ...	Grant	A	0.00	36,489	0	109,361	72.9 K to 109.4 K (+50.07 %)
Oct 05 2007	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	Exec VP, Pres Brand ...	Buy	P	18.70	3,000	56,100	11,407	8.4 K to 11.4 K (+35.68 %)
Mar 26 2007	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	Exec VP, Pres Brand ...	Option Exercise	A	24.27	10,800	262,116	10,800
Mar 26 2007	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	Exec VP, Pres Brand ...	Grant	A	0.00	20,700	0	49,328	28.6 K to 49.3 K (+72.31 %)
Dec 22 2006	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	Pres. Branded Produ ...	Grant	A	0.00	21,600	0	21,600	0 to 21.6 K
Jan 11 2006	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	Pres, Branded Produ ...	Option Exercise	A	33.62	18,319	615,885	18,319
Jan 11 2006	PRX	PAR PHARMACEUTICAL ...	MacPhee John A	Pres, Branded Produ ...	Grant	A	0.00	16,128	0	23,628	7.5 K to 23.6 K (+215.04 %)

Page: 1